Employee Benefit Plans (Tables)

9 Months Ended

Mar. 31, 2022

Share Based Compensation [Abstract]

Common Stock Reserved for Future Issuance

The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):

	March 31, 2022		June 30, 2021
2013 Equity Incentive Plan shares available for grant		11,173		6,753
Employee stock options and awards outstanding		8,415		10,359
2014 Employee Stock Purchase Plan		9,961		4,414
Total shares reserved for issuance		29,549		21,526

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	March 31, 2022		March 31, 2021		March 31, 2022		March 31, 2021
Cost of product revenues	$	291	$	297	$	904	$	869
Cost of service and subscription revenues		343		412		1,056		1,223
Research and development		2,446		2,414		7,568		7,380
Sales and marketing		3,832		3,150		11,267		9,036
General and administrative		3,941		2,925		11,835		9,087
Total share-based compensation expense	$	10,853	$	9,198	$	32,630	$	27,595

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended March 31, 2022 (in thousands, except per share and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2021		1,645		$	5.44		3.62	$	9,404
Granted		—			—
Exercised		(431	)		2.54
Cancelled		—			—
Options outstanding at March 31, 2022		1,214		$	6.47		3.86	$	6,963
Vested and expected to vest at March 31, 2022		1,214		$	6.47		3.86	$	6,963
Exercisable at March 31, 2022		975		$	6.42		3.73	$	5,647

Summary of Stock Award Activity

The following table summarizes stock award activity for the nine months ended March 31, 2022 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Value
Non-vested stock awards outstanding at June 30, 2021		8,714		$	5.51
Granted		4,182			11.45
Released		(5,302	)		5.27
Cancelled		(393	)		6.69
Non-vested stock awards outstanding at March 31, 2022		7,201		$	9.07	$	87,928
Stock awards expected to vest at March 31, 2022		7,201		$	9.07	$	87,928

Schedule of Awards Performance Thresholds and Shares Expected to Vest (TSR PSUs)

The MSU award represents the right to receive a target number of shares of common stock of up to 150% of the original grant. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance.

Level	Relative TSR	Shares Vested
Below Threshold	TSR is less than the Index by more than 37.5 percentage points	0%
Threshold	TSR is less than the Index by 37.5 percentage points	25%
Target	TSR equals the Index	100%
Maximum	TSR is greater than the Index by 25 percentage points or more	150%

Schedule of Fair Value Assumptions for Employee Stock Purchase Plan Awards

The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:

	Employee Stock Purchase Plan						Employee Stock Purchase Plan
	Three Months Ended						Nine Months Ended
	March 31, 2022			March 31, 2021			March 31, 2022			March 31, 2021
Expected life	0.5 years			0.5 years			0.5 years			0.5 years
Risk-free interest rate		0.67	%		0.05	%		0.33	%		0.09	%
Volatility		45	%		55	%		49	%		95	%
Dividend yield		—	%		—	%		—	%		—	%